Explore how innovative packaging strategies are helping life sciences companies maintain product integrity and meet sustainability goals. A timely look at balancing compliance, safety, and environmental impact. Download Podcast and Q&A: hubs.li/Q03jSSYR0

In an exclusive interview at #asembia25, Will Pih of Two Labs explains how specialty pharmacies and manufacturers are adapting to financial pressures in #raredisease care through patient-centric services, hub innovation, and hybrid technology models. pharmaceuticalcommerce.com/view/asembia-2…

Antares Vision Group is growing its solutions portfolio to now include precision labeling equipment. The company is collaborating with Siempharma S.r.l., a manufacturer of packaging machines, by welcoming the ETF-300. #lifesciences #trackandtrace pharmaceuticalcommerce.com/view/antares-v…

📊 Pharma needs a metric makeover. AI & DTP can unlock $100B+ in value—but only if we align KPIs with patient outcomes, not just sales. EVERSANA #Pharma #DigitalHealth #AI #PatientCentricity #HealthcareInnovation pharmaceuticalcommerce.com/view/measuring…

Similar to tariffs in which Trump felt that the United States was not treated fairly when it came to be taxed on certain imports, the executive order notes that Americans “unwittingly sponsor” drug manufacturers and other nations. pharmaceuticalcommerce.com/view/white-hou…

Learn about the new KPIs needed to unlock these opportunities and redefine success in the life sciences industry in this latest article written by Scott Snyder for the May issue of Pharmaceutical Commerce. Learn more here: eversana.com/insights/trend…

🚨 UnitedHealth CEO Andrew Witty steps down amid a turbulent year—DOJ probe, 190M-person data breach, and a tragic exec murder. Former CEO Stephen Hemsley returns as shares hit a 4-year low. #Healthcare #Leadership #UnitedHealth pharmaceuticalcommerce.com/view/white-hou…

🚨 95% of rare diseases lack FDA-approved treatments. New study highlights how nonprofits drive drug repurposing success—via patient recruitment, a 5-step framework, and a new DDDR). 💊 #RareDisease #DrugRepurposing #HealthcareInnovation pharmaceuticalcommerce.com/view/themes-am…

14M Medicare beneficiaries rely on the Low-Income Subsidy (LIS) for affordable meds. A new NEJM study shows losing LIS—often due to Medicaid disenrollment—is linked to higher mortality. #Medicare #HealthEquity #LIS pharmaceuticalcommerce.com/view/how-loss-…

Herspiegel Consulting Dives Into the Value Narrative Kapil Raina, MD, talks disconnects in the industry, patient access to healthcare information, and the future of pharmaceutical manufacturing and patient care.  Watch video: hubs.ly/Q03mL3pC0

🚨 Noom is now selling compounded microdoses of semaglutide (Wegovy’s active ingredient) for $149/month via telehealth. Full story: pharmaceuticalcommerce.com/view/noom-to-s… #Noom #GLP1 #Wegovy #Telehealth #WeightLoss #PharmaNews

503B outsourcing facilities are held to strict FDA cGMP standards — raising the bar for safety & quality in compounded drugs. ✅ Higher trust ⚠️ Higher compliance costs Kurt Lunkwitz of ProRX Pharma chat with us: pharmaceuticalcommerce.com/view/an-explor…

Mercalis & PharmaCord have merged to form Valeris—a next-gen biopharma commercialization partner backed by Permira & Odyssey. The goal? Simplify access, boost adherence & accelerate patient outcomes. A major shift for patient support. #LifeSciences pharmaceuticalcommerce.com/view/mercalis-…

Pharma’s future hinges on CX. With DTC & DTP models rising, seamless, personalized experiences drive both prescriptions & patient trust. AI + omnichannel tech = game changers. pharmaceuticalcommerce.com/view/why-cx-di…

🚨 U.S. pharma tariffs could raise drug costs by $51B/year and spike prices nearly 13%. API sourcing, medtech, and R&D all feel the pressure. Companies are reshoring, but it’s a long road. #Pharma #Tariffs #SupplyChain #medtech pharmaceuticalcommerce.com/view/tariff-ef…

🗺️ 17.7% of Americans live in #pharmacydeserts. Geospatial tools can map closures and assess barriers like transit, car access, and internet to spot emerging gaps & target solutions. Our chat with Maggie McCullough of PolicyMap: pharmaceuticalcommerce.com/view/how-geosp… #HealthEquity #GIS

New study in JAMA Network Open finds key differences in full-benefit dual-eligible enrollees across Medicare Advantage plans. #Medicare #Medicaid #HealthEquity pharmaceuticalcommerce.com/view/variation…

Pharma’s old model doesn’t work in a value-based care world. To thrive, companies must shift from promotion to partnership with IDNs—driven by data, outcomes & shared value. #Pharma #ValueBasedCare #IDNs #HealthcareInnovation pharmaceuticalcommerce.com/view/bridging-…

Beyond Awareness: Modeling Shared Decision-Making in Patient Communications Most patient education gives information, but patients need more. Shared decision-making stories show real patient–provider talks on how to engage in care. Learn more: hubs.li/Q03qSt0q0

Serialization 2.0 = open, scalable, and AI-ready systems that go beyond compliance to drive agility, cost savings, and innovation. Is your serialization strategy future-ready? pharmaceuticalcommerce.com/view/serializa… #Serialization #DigitalTransformation #PharmaTech